Versatile bifunctional PYTA derivatives for actinium-225 radiolabeling: a comparison to gold standards

20 February 2025, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

We report the synthesis of the first PYTA bifunctional chelators designed for the coordination of actinium-225 and their bioconjugation to biovectors of interest. Three PYTA bifunctional chelators, PY3A, PYTA-GA, and PYTA-PE, were synthesized. A comparative study with current gold standards, MacropaTM, DOTA and Crown derivatives, highlights the excellent radiochemical properties and prolonged in vitro stability of PYTA derivatives. These exceptional performances were validated further through conjugation to a small PSMA ligand and two antibodies with quantitative radiolabeling under smooth conditions (37°C, low concentration). In vivo evaluation of radioimmunoconjugates further confirmed the prolonged stability of PYTA conjugates, yielding pharmacokinetic results comparable to Macropa™, while revealing clear in vivo instability of the Crown derivative. These findings underscore the potential of PYTA to emerge as the next gold-standard chelator for actinium-225, comparable to Macropa™, with the added advantages of easier synthesis of bifunctional derivatives and greater versatility for radiolabeling with other radionuclides.

Keywords

Bifunctional chelator
Actinium-225
radiochemistry
alpha emitter
targeted alpha therapy

Supplementary materials

Title
Description
Actions
Title
Supporting information
Description
Materials and methods, additional figures
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.